Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
Advances in molecular genetics present new opportunities and challenges for cardiologists who manage patients and families with cardiomyopathies. The aims of this position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases are to review the general issues related to genetic counselling, family screening and genetic testing in families with a cardiomyopathy, and to provide key messages and suggestions for clinicians involved in their management.
Charron
Philippe
P
UPMC Univ Paris 6, AP-HP, Hôpital Pitié-Salpêtrière, Centre de Référence Maladies cardiaques héréditaires, Paris, France.
Arad
Michael
M
Arbustini
Eloisa
E
Basso
Cristina
C
Bilinska
Zofia
Z
Elliott
Perry
P
Helio
Tiina
T
Keren
Andre
A
McKenna
William J
WJ
Monserrat
Lorenzo
L
Pankuweit
Sabine
S
Perrot
Andreas
A
Rapezzi
Claudio
C
Ristic
Arsen
A
Seggewiss
Hubert
H
van Langen
Irene
I
Tavazzi
Luigi
L
D009202:Cardiomyopathies / Q000175:diagnosis / Q000235:genetics* / Q000517:prevention & control; D005260:Female; D005817:Genetic Counseling / Q000379:methods*; D005820:Genetic Testing / Q000379:methods*; D006801:Humans; D009154:Mutation / Q000235:genetics; D010375:Pedigree; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000379:methods; D011379:Prognosis; D012008:Recurrence